Skip to main content
Clinical Trials/NCT00967720
NCT00967720CompletedNot Applicable

Qualitative Analysis of the Barriers to Adherence With Asthma Controller Medication Among Inner City African American Adolescents as Identified Through Focus Group Data

Rush University Medical Center0 sites4 target enrollmentStarted: March 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
4
Primary Endpoint
Focus groups explored whether a new communication medium improved adherence to asthma controller medications and to examine existing barriers to adherence among four urban African American adolescents with uncontrolled moderate persistent asthma

Study Overview

Brief Summary

Poor adherence to appropriate asthma medications is an important risk factor contributing to high asthma morbidity and mortality in urban African American adolescents. As part of the ADEPT (Adolescent Disease Empowerment and Persistency Technology) for Asthma Pilot 2 study, a focus group was developed specifically to explore existing barriers to adherence among inner city African American adolescent asthmatics.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
12 Years to 15 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 12-18 years of age
  • self identify as African American
  • have persistent asthma
  • read at a minimum fourth grade reading level
  • be on a prescribed daily inhaled corticosteroid medication for asthma

Exclusion Criteria

  • candidate refusal or presence of other co-morbidities

Outcomes

Primary Outcomes

Focus groups explored whether a new communication medium improved adherence to asthma controller medications and to examine existing barriers to adherence among four urban African American adolescents with uncontrolled moderate persistent asthma

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Similar Trials

Barriers to Adherence to Asthma Controller... | Clinical Trial